Broad Institute Responds to UC Berkeley Appeal of CRISPR-Cas9 Patent Interference Decision – GenomeWeb
|
Broad Institute Responds to UC Berkeley Appeal of CRISPR-Cas9 Patent Interference Decision
GenomeWeb In January, the US Patent and Trademark Office declared an interference proceeding to settle certain claims related to the CRISPR patent battle between parties led by the Broad and the University of California. In the interference proceedings, the … |
